Mostra risultati da 1 a 20 di 40
successivo >
Titolo Data di pubblicazione Autore(i) Rivista Editore
Protective Agents in Parkinson’s Disease: Caffeine and Adenosine A2A Receptor Antagonists 2021 Simola, Nicola; Pinna, Annalisa; Frau, Lucia; Costa, Giulia; Marongiu, Jacopo; Parekh, Pathik; Se...rra, Marcello; Morelli, Micaela Springer Nature Switzerland
Widespread reduction of dopamine cell bodies and terminals in adult rats exposed to a low dose regimen of MDMA during adolescence 2017 Cadoni, Cristina; Pisanu, Augusta; Simola, Nicola; Frau, Lucia; Porceddu, PIER FRANCESCA; Corongi...u, Silvia; Dessi', Christian; Sil, Annesha; Plumitallo, Antonio; Wardas, Jadwiga; DI CHIARA, Gaetano NEUROPHARMACOLOGY
Influence of caffeine on 3,4-methylenedioxymethamphetamine-induced dopaminergic neuron degeneration and neuroinflammation is age-dependent 2016 Frau, Lucia; Costa, Giulia; Porceddu, Pier Francesca; Khairnar, Amit; Castelli, Maria Paola; Enna...s, Maria Grazia; Madeddu, Camilla; Wardas, Jadwiga; Morelli, Micaela JOURNAL OF NEUROCHEMISTRY
Novel (Hetero)arylalkenyl propargylamine compounds are protective in toxin-induced models of Parkinson's disease 2016 Baranyi, M; Porceddu, Pf; Goloncser, F; Kulcsar, S; Otrokocsi, L; Kittel, A; Pinna, A; Frau, L; H...uleatt, Pb.; Khoo, Ml; Chai, Cll.; Dunkel, P; Matyus, P; Morelli, M; Sperlagh, B MOLECULAR NEURODEGENERATION
Effect of crowding, temperature and age on glia activation and dopaminergic neurotoxicity induced by MDMA in the mouse brain 2016 Frau, Lucia; Simola, Nicola; Porceddu, PIER FRANCESCA; Morelli, Micaela NEUROTOXICOLOGY
Antagonism of Adenosine A1 or A2A Receptors Amplifies the Effects of 3,4-Methylendioxymethamphetamine (MDMA) on Glial Activation in the Mouse Brain: Relevance to Caffeine-MDMA Interactions 2014 KHAIRNAR A; FRAU L; PLUMITALLO A; MORELLI M; SIMOLA N JOURNAL OF CAFFEINE RESEARCH
Direct and long-lasting effects elicited by repeated drug administration on 50-kHz ultrasonic vocalizations are regulated differently: Implications for the study of the affective properties of drugs of abuse 2014 SIMOLA N; FRAU L; PLUMITALLO A; MORELLI M INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
Protective Agents in Parkinson's Disease: Caffeine and Adenosine A2A Receptor Antagonists 2014 SIMOLA N; PINNA A; FRAU L; MORELLI M Springer
Contribution of Caffeine to the Psychostimulant, Neuroinflammatory and Neurotoxic Effects of Amphetamine-Related Drugs 2013 FRAU L; SIMOLA N; MORELLI M JOURNAL OF CAFFEINE RESEARCH
MPTP-induced dopamine neuron degeneration and glia activation is potentiated in MDMA pretreated mice 2013 COSTA G; FRAU L; WARDAS J; PINNA A; PLUMITALLO A; MORELLI M MOVEMENT DISORDERS
Role of movement in long-term basal ganglia changes: implications for abnormal motor responses 2013 SIMOLA N; MORELLI M; FRAZZITTA G; FRAU L FRONTIERS IN COMPUTATIONAL NEUROSCIENCE
Symptomatic and Neuroprotective Effects of A2A Receptor Antagonists in Parkinson’s Disease 2013 PINNA A; SIMOLA N; FRAU L; MORELLI M Springer Science
Performance of movement in hemiparkinsonian rats influences the modifications induced by dopamine agonists in striatal efferent dynorphinergic neurons 2013 FRAU L; MORELLI M; SIMOLA N EXPERIMENTAL NEUROLOGY
Microglial and astroglial activation by 3,4-methylenedioxymethamphetamine (MDMA) in mice depends on S(+) enantiomer and is associated with an increase in body temperature and motility 2013 FRAU L; SIMOLA N; PLUMITALLO A; MORELLI M JOURNAL OF NEUROCHEMISTRY
Alteration in the progression of dopamine neuron degeneration: May caffeine offer new perspective? 2012 MORELLI M; FRAU L; SIMOLA N EXPERIMENTAL NEUROLOGY
Late-onset Parkinsonism in NFκB/c-Rel-deficient mice 2012 Baiguera, C; Alghisi, M; Pinna, A; Bellucci, A; DE LUCA, Ma; Frau, L; Morelli, M; Ingrassia, R; B...enarese, M; Porrini, V; Pellitteri, M; Bertini, G; Fabene, Pf; Sigala, S; Spillantini, Mg; Liou, Hc; Spano, Pf; Pizzi, M BRAIN
PPAR-gamma agonist rosiglitazone inhibits TNF-alpha production by microglia and arrests nigrostriatal degeneration in a progressive Parkinson’s disease model. 2011 CARTA A; PISANU A; FRAU L; SPIGA S; CARBONI E SOC. NEUROSCI. ABSTR., 41TH ANNUAL MEETING SOCIETY FOR NEUROSCIENCE, WASHINGTON D.C., 12-16 NOVEMBRE 2011 Society for Neuroscience
Effect of adenosine A1 and A2A antagonists on 3,4 methylenedioxymethamphetamine (MDMA)-induced neuroinflammation and dopamine neuron toxicity in mouse brain 2011 Khairnar A; Frau L; Fenu S; Plumitallo A; Morelli M
Caffeine potentiation of 3,4-methylenedioxymethamphetamine (MDMA) toxicity: role of age 2011 Frau L; Khairnar A; Fenu S; Morelli M
A442 PPAR-gamma agonist rosiglitazone inhibits TNF-alpha production by microglia and arrests neurodegeneration in a progressive Parkinson´s disease model 2011 CARTA AR; PISANU A; FRAU L; SPIGA S; CARBONI E International brain resesearch organization

Questionario e social

Condividi su: